<DOC>
	<DOCNO>NCT01239251</DOCNO>
	<brief_summary>The purpose study test ease use new device , call GlowCap remind patient take breast cancer hormone pill . The study collect information experience device patient think role daily pill take routine .</brief_summary>
	<brief_title>GlowCap Reminder System Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Early stage breast cancer patient take adjuvant endocrine therapy ( ie , tamoxifen , anastrozole , letrozole , exemestane ) . Age â‰¥ 60 year Must broadband internet access home ( enable base system communicate Vitality server ) . Must landline mobile phone NonEnglish speaking patient</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>GlowCap</keyword>
	<keyword>adjuvant endocrine therapy</keyword>
</DOC>